Thomas Von Hahn

Title: Innovations of Thomas Von Hahn

Introduction

Thomas Von Hahn is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of virology, particularly in understanding Hepatitis C virus (HCV) interactions with human cells. His work has led to the development of innovative methods for preventing and mitigating HCV infections.

Latest Patents

Thomas Von Hahn holds 2 patents related to his groundbreaking research. His latest patents focus on the discovery that the Claudin-1 protein functions as a co-receptor for the entry of HCV into cells. The inventions provide methods for inhibiting, preventing, or mitigating HCV infections by targeting HCV interactions with Claudin-1. Additionally, they include methods for identifying agents or compounds that interfere with these interactions. The patents also disclose useful kits, cell culture compositions, agents, and compounds related to the inhibition of HCV interactions with Claudin-1.

Career Highlights

Thomas Von Hahn is affiliated with The Rockefeller University, where he conducts his research. His work has been instrumental in advancing the understanding of HCV and its mechanisms of infection. His innovative approaches have the potential to lead to new therapeutic strategies for combating HCV.

Collaborations

Throughout his career, Thomas has collaborated with esteemed colleagues, including Charles Moen Rice, III, and Matthew Evans. These collaborations have further enriched his research and contributed to the scientific community's understanding of HCV.

Conclusion

Thomas Von Hahn's contributions to the field of virology, particularly regarding HCV, highlight the importance of innovation in medical research. His patents and collaborative efforts continue to pave the way for advancements in the prevention and treatment of viral infections.